Class information for: |
Basic class information |
Class id | #P | Avg. number of references |
Database coverage of references |
---|---|---|---|
17072 | 619 | 43.4 | 77% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
11 | 4 | NEUROSCIENCES//CLINICAL NEUROLOGY//NEUROL | 1112395 |
124 | 3 | PARKINSONS DISEASE//MOVEMENT DISORDERS//DEEP BRAIN STIMULATION | 67777 |
166 | 2 | PARKINSONS DISEASE//MOVEMENT DISORDERS//MULTIPLE SYSTEM ATROPHY | 22593 |
17072 | 1 | VISUAL HALLUCINATIONS//HALLUCINATIONS//PARKINSONS DISEASE PSYCHOSIS | 619 |
Terms with highest relevance score |
rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|---|
1 | VISUAL HALLUCINATIONS | authKW | 829341 | 11% | 25% | 68 |
2 | HALLUCINATIONS | authKW | 415395 | 16% | 9% | 98 |
3 | PARKINSONS DISEASE PSYCHOSIS | authKW | 350781 | 1% | 89% | 8 |
4 | DOPAMINERGIC PSYCHOSIS | authKW | 205535 | 1% | 83% | 5 |
5 | PIMAVANSERIN | authKW | 172644 | 1% | 50% | 7 |
6 | DRUG INDUCED PSYCHOSIS | authKW | 170087 | 2% | 34% | 10 |
7 | PARKINSONS DISEASE | authKW | 162249 | 51% | 1% | 314 |
8 | DOPAMIMETIC PSYCHOSIS | authKW | 147987 | 0% | 100% | 3 |
9 | ATTENTIONAL CONTROL NETWORKS | authKW | 98658 | 0% | 100% | 2 |
10 | BISTABLE PERCEPT PARADIGM | authKW | 98658 | 0% | 100% | 2 |
Web of Science journal categories |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | Clinical Neurology | 14198 | 65% | 0% | 403 |
2 | Psychiatry | 2678 | 24% | 0% | 150 |
3 | Neurosciences | 748 | 22% | 0% | 136 |
4 | Geriatrics & Gerontology | 745 | 6% | 0% | 38 |
5 | Pharmacology & Pharmacy | 383 | 17% | 0% | 103 |
6 | Gerontology | 247 | 3% | 0% | 17 |
7 | Medicine, General & Internal | 24 | 5% | 0% | 29 |
8 | Neuroimaging | 10 | 1% | 0% | 4 |
9 | Psychology | 9 | 1% | 0% | 8 |
10 | Behavioral Sciences | 8 | 1% | 0% | 8 |
Address terms |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | STATE COGNIT SCI | 88790 | 0% | 60% | 3 |
2 | ALPERT MED BUTLER HOSP | 49329 | 0% | 100% | 1 |
3 | AMU CNRS | 49329 | 0% | 100% | 1 |
4 | ATROPHIE MULTI SYSTEMATISEE | 49329 | 0% | 100% | 1 |
5 | BIOSIGNAL ANAL MED IMAGING GRP | 49329 | 0% | 100% | 1 |
6 | CHEF SERV MAISON ADDICT | 49329 | 0% | 100% | 1 |
7 | CLIN AGING UNIT | 49329 | 0% | 100% | 1 |
8 | CLIN NEROSCI | 49329 | 0% | 100% | 1 |
9 | CLIN NEUROCIENCIASHOSP CLIN | 49329 | 0% | 100% | 1 |
10 | CLIN NEUROCIENCIESNEUROL SERV | 49329 | 0% | 100% | 1 |
Journals |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | MOVEMENT DISORDERS | 52206 | 13% | 1% | 83 |
2 | CLINICAL NEUROPHARMACOLOGY | 19782 | 5% | 1% | 31 |
3 | PARKINSONISM & RELATED DISORDERS | 12861 | 4% | 1% | 25 |
4 | JOURNAL OF NEUROPSYCHIATRY AND CLINICAL NEUROSCIENCES | 7578 | 2% | 1% | 15 |
5 | PARKINSONS DISEASE | 4247 | 1% | 1% | 6 |
6 | JOURNAL OF GERIATRIC PSYCHIATRY AND NEUROLOGY | 4079 | 1% | 1% | 8 |
7 | NEUROLOGY | 3504 | 6% | 0% | 39 |
8 | BEHAVIOURAL NEUROLOGY | 1668 | 1% | 1% | 5 |
9 | PHARMAKOPSYCHIATRIE NEURO-PSYCHOPHARMAKOLOGIE | 1201 | 0% | 2% | 1 |
10 | JOURNAL OF PARKINSONS DISEASE | 1169 | 0% | 1% | 3 |
Author Key Words |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | VISUAL HALLUCINATIONS | 829341 | 11% | 25% | 68 | Search VISUAL+HALLUCINATIONS | Search VISUAL+HALLUCINATIONS |
2 | HALLUCINATIONS | 415395 | 16% | 9% | 98 | Search HALLUCINATIONS | Search HALLUCINATIONS |
3 | PARKINSONS DISEASE PSYCHOSIS | 350781 | 1% | 89% | 8 | Search PARKINSONS+DISEASE+PSYCHOSIS | Search PARKINSONS+DISEASE+PSYCHOSIS |
4 | DOPAMINERGIC PSYCHOSIS | 205535 | 1% | 83% | 5 | Search DOPAMINERGIC+PSYCHOSIS | Search DOPAMINERGIC+PSYCHOSIS |
5 | PIMAVANSERIN | 172644 | 1% | 50% | 7 | Search PIMAVANSERIN | Search PIMAVANSERIN |
6 | DRUG INDUCED PSYCHOSIS | 170087 | 2% | 34% | 10 | Search DRUG+INDUCED+PSYCHOSIS | Search DRUG+INDUCED+PSYCHOSIS |
7 | PARKINSONS DISEASE | 162249 | 51% | 1% | 314 | Search PARKINSONS+DISEASE | Search PARKINSONS+DISEASE |
8 | DOPAMIMETIC PSYCHOSIS | 147987 | 0% | 100% | 3 | Search DOPAMIMETIC+PSYCHOSIS | Search DOPAMIMETIC+PSYCHOSIS |
9 | ATTENTIONAL CONTROL NETWORKS | 98658 | 0% | 100% | 2 | Search ATTENTIONAL+CONTROL+NETWORKS | Search ATTENTIONAL+CONTROL+NETWORKS |
10 | BISTABLE PERCEPT PARADIGM | 98658 | 0% | 100% | 2 | Search BISTABLE+PERCEPT+PARADIGM | Search BISTABLE+PERCEPT+PARADIGM |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
---|---|---|---|---|
1 | CHANG, A , FOX, SH , (2016) PSYCHOSIS IN PARKINSON'S DISEASE: EPIDEMIOLOGY, PATHOPHYSIOLOGY, AND MANAGEMENT.DRUGS. VOL. 76. ISSUE 11. P. 1093 -1118 | 150 | 53% | 2 |
2 | FFYTCHE, DH , CREESE, B , POLITIS, M , CHAUDHURI, KR , WEINTRAUB, D , BALLARD, C , AARSLAND, D , (2017) THE PSYCHOSIS SPECTRUM IN PARKINSON DISEASE.NATURE REVIEWS NEUROLOGY. VOL. 13. ISSUE 2. P. 81 -95 | 118 | 69% | 0 |
3 | LERTXUNDI, U , RUIZ, AI , ASPIAZU, MAS , DOMINGO-ECHABURU, S , GARCIA, M , AGUIRRE, C , GARCIA-MONCO, JC , (2015) ADVERSE REACTIONS TO ANTIPSYCHOTICS IN PARKINSON DISEASE: AN ANALYSIS OF THE SPANISH PHARMACOVIGILANCE DATABASE.CLINICAL NEUROPHARMACOLOGY. VOL. 38. ISSUE 3. P. 69 -84 | 78 | 90% | 6 |
4 | FRIEDMAN, JH , (2013) PARKINSON DISEASE PSYCHOSIS: UPDATE.BEHAVIOURAL NEUROLOGY. VOL. 27. ISSUE 4. P. 469-477 | 79 | 81% | 16 |
5 | ZAHODNE, LB , FERNANDEZ, HH , (2008) PATHOPHYSIOLOGY AND TREATMENT OF PSYCHOSIS IN PARKINSON'S DISEASE - A REVIEW.DRUGS & AGING. VOL. 25. ISSUE 8. P. 665-682 | 87 | 67% | 77 |
6 | HASNAIN, M , (2011) PSYCHOSIS IN PARKINSON'S DISEASE: THERAPEUTIC OPTIONS.DRUGS OF TODAY. VOL. 47. ISSUE 5. P. 353-367 | 76 | 82% | 6 |
7 | FRIEDMAN, JH , (2010) PARKINSON'S DISEASE PSYCHOSIS 2010 A REVIEW ARTICLE.PARKINSONISM & RELATED DISORDERS. VOL. 16. ISSUE 9. P. 553 -560 | 61 | 77% | 37 |
8 | GOLDMAN, JG , VAUGHAN, CL , GOETZ, CG , (2011) AN UPDATE EXPERT OPINION ON MANAGEMENT AND RESEARCH STRATEGIES IN PARKINSON'S DISEASE PSYCHOSIS.EXPERT OPINION ON PHARMACOTHERAPY. VOL. 12. ISSUE 13. P. 2009 -2024 | 63 | 75% | 18 |
9 | OJO, OO , FERNANDEZ, HH , (2016) CURRENT UNDERSTANDING OF PSYCHOSIS IN PARKINSON'S DISEASE.CURRENT PSYCHIATRY REPORTS. VOL. 18. ISSUE 10. P. - | 55 | 77% | 0 |
10 | DIVAC, N , STOJANOVIC, R , VUJOVIC, KS , MEDIC, B , DAMJANOVIC, A , PROSTRAN, M , (2016) THE EFFICACY AND SAFETY OF ANTIPSYCHOTIC MEDICATIONS IN THE TREATMENT OF PSYCHOSIS IN PATIENTS WITH PARKINSON'S DISEASE.BEHAVIOURAL NEUROLOGY. VOL. . ISSUE . P. - | 49 | 82% | 0 |
Classes with closest relation at Level 1 |